Treating HCV infection in children

Clinical Liver Disease

Volumn 5, Issue 1, 2015, Pages 14-16

  Lee, Christine K ^a   Jonas, Maureen M ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BOCEPREVIR; DIRECT ACTING ANTIVIRAL AGENT; INTERFERON; INTERLEUKIN 28B; PEGINTERFERON; PEGINTERFERON 2A; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; SOFOSBUVIR; TELAPREVIR; UNCLASSIFIED DRUG; VIRUS RNA;

BODY MASS; CANADA; CHILD; COMORBIDITY; DEPRESSION; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG TOLERABILITY; EUROPEAN UNION; FEVER; GASTROINTESTINAL SYMPTOM; GENOTYPE; HEADACHE; HEMOLYTIC ANEMIA; HEPATITIS C; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; LICENSING; LIVER BIOPSY; LIVER DISEASE; MORTALITY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NORTH AMERICA; OPHTHALMOLOGY; ORGAN TRANSPLANTATION; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; RETINOPATHY; REVIEW; RISK REDUCTION; RUSSIAN FEDERATION; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; TERATOGENICITY; TREATMENT DURATION; TREATMENT RESPONSE; UNITED STATES; UVEITIS; WEIGHT REDUCTION;

EID: 84923933055     PISSN: None     EISSN: 20462484     Source Type: Journal    
DOI: 10.1002/cld.439     Document Type: Review

References (13)

1. Jhaveri R. Diagnosis and management of hepatitis C virus-infected children. Pediatr Infect Dis J 2011;30:983-985.
2. Jara P, Resti M, Hierro L, Giacchino R, Barbera C, Zancan L, et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis 2003;36:275-280.
3. Badizadegan K, Jonas MM, Ott MJ, Nelson SP, Perez-Atayde AR. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998;28:1416-1423.
4. Guido M, Rugge M, Jara P, Hierro L, Giacchino R, Larrauri J, et al. Chronic hepatitis C in children: the pathological and clinical spectrum. Gastroenterology 1998;115:1525-1529.
5. Goodman ZD, Makhlouf HR, Liu L, Balistreri W, Gonzalez-Peralta RP, Haber B, et al. Pathology of chronic hepatitis C in children: liver biopsy findings in the PEDS-C trial. Hepatology 2008;47:836-843.
6. Mohan P, Barton BA, Narkewicz MR, Molleston JP, Gonzalez-Peralta RP, Rosenthal P, et al. Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study. Hepatology 2013;58:1580-1586.
7. Minola E, Prati D, Suter F, Maggiolo F, Caprioli F, Sonzogni A, et al. Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood 2002;99:4588-4591.
8. Casiraghi MA, De Paschale M, Romano L, Biffi R, Assi A, Binelli G, et al. Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusion of blood given at birth. Hepatology 2004;39:90-96.
9. Birnbaum AH, Shneider BL, Moy L. Hepatitis C in children. N Engl J Med 2000;342:290-291.
10. Schwarz KB, Gonazalez-Peralta RP, Murray KF, Molleston JP, Haber BA, Jonas MM, et al. The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C. Gastroenterology 2011;140:450-458.
11. Jonas MM, Balistreri W, Gonzalez-Peralta RP, Haber B, Lobritto S, Mohan P, et al. Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trial. Hepatology 2012;56:523-531.
12. Recommendations for testing, managing and treating hepatitis C. Joint panel from the American Association of the Study of Liver Diseases and the Infectious Diseases Society of America. http://wwww.hcvguidelines.org. Accessed August 2014.
13. Narkewicz MR, Rosenthal P, Schwarz KB, Drack A, Margolis T, Repka MX, et al. Ophthalmologic complications in children with chronic hepatitis C treated with pegylated interferon. J Pediatr Gastroenterol Nutr 2010;51:183-186.